What does Foresite Capital invest in?
Foresite Capital invests most often at Series B and Series C (64% of the rounds on record), in sectors such as Healthcare, Wellness and Longevity.
United States · Investor
Last cheque observed Sep 2026; 121 cheques on record.
Deploying nowNew fund $85M, Oct 2023Private equityWebsite unconfirmed
Follow Foresite Capital and see its new cheques in your feed.Start following
27 cheques in the last 12 months
Mostly Series B and Series C: 64% of its rounds
Sole investor in 4 rounds, median $78M
2 exits from the portfolio
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
Every round we can evidence, newest first121 appearances
22 rounds
24 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
We also hold 25 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
9 private funds, $3.5B in gross assets · filed Mar 2024
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it backed that were later bought or listed2 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Foresite Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Foresite Capital put money into.
Episodes that name Foresite Capital in their description, not their title.

Investor Stories 484: Why Selling Too Early Hurts Returns, The Leadership Power of Sleep, and The Costliest Investment Mistakes (Tananbaum, Ries, Demaree)

Investor Stories 472: Think Big, Stay Patient, Earn Access, Venture Advice from Foresite, Mayfield, and Blue Moon (Tananbaum, Chaddha, Orthlieb)

Investor Stories 466: Jim Tananbaum, Eric Byunn, and Ben Orthlieb on the Questions LPs Should Be Asking (Tananbaum, Orthlieb, Byunn)
WithBen OrthliebEric ByunnJim Tananbaum
MentionsForesite Capital

Investor Stories 463: Selling Transformation Not Software, Managing Through Activists and Mergers, and Scaling Culture with Intent (Agarwal, Tananbaum, Cohen)
MentionsDavid CohenForesite CapitalTechstars+2

Investor Stories 451: Why I Passed: Moving Too Slowly, Misreading Return Drivers, and Passing on Lyft (Banks, Tananbaum, Cohen)
MentionsDavid CohenForesite CapitalTechstars+2
Foresite Capital invests most often at Series B and Series C (64% of the rounds on record), in sectors such as Healthcare, Wellness and Longevity.
121 investments on record, 27 of them in the last 12 months, and it led 3. The most recent was in Sept 2026.
Its most recent investments on record: Intellia Therapeutics (Debt, Sept 2026), Tempest Therapeutics (Undisclosed round, Sept 2026) and Thyme Care (Series E, Sept 2026).
The median round it joins is $90M. It says it writes cheques of $100K to $5.0M.
Sometimes: it led 3 of its 121 investments on record (2%).
Most of the companies it backs are in the United States (92%).
Yes: it is actively investing, with 27 investments in the last 12 months.
Most often RA Capital Management (26 rounds together), OrbiMed (22 rounds together) and Cormorant Asset Management (17 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it